ketoconazole and quizartinib

ketoconazole has been researched along with quizartinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gammon, G; Kankam, M; Li, J; Trone, D	1

Trials

1 trial(s) available for ketoconazole and quizartinib

Article	Year
Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite. British journal of clinical pharmacology, 2019, Volume: 85, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Benzothiazoles; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluconazole; fms-Like Tyrosine Kinase 3; Healthy Volunteers; Humans; Invasive Fungal Infections; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Phenylurea Compounds; Young Adult	2019

Article

Year

Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite.

British journal of clinical pharmacology, 2019, Volume: 85, Issue:9

Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Benzothiazoles; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluconazole; fms-Like Tyrosine Kinase 3; Healthy Volunteers; Humans; Invasive Fungal Infections; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Phenylurea Compounds; Young Adult

2019